UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 413

Sortiert nach

The elusive definition of pandemic influenza

Bulletin of the World Health Organization, 2011-07, Vol.89 (7), p.532-538

DOSHI, Peter

2011

Link zum Volltext

Verfügbarkeit prüfen

The imperative to share clinical study reports: recommendations from the Tamiflu experience

PLoS medicine, 2012-04, Vol.9 (4), p.e1001201

2012

Link zum Volltext

Verfügbarkeit prüfen

Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry

BMJ (Online), 2024-05, Vol.385, p.q975

Doshi, Peter

2024

Link zum Volltext

Verfügbarkeit prüfen

Covid-19 vaccine trial protocols released

BMJ (Online), 2020-10, Vol.371, p.m4058

Doshi, Peter

2020

Link zum Volltext

Verfügbarkeit prüfen

Did the FDA break its own rules in approving the antibiotic Recarbrio?

BMJ (Online), 2023-05, Vol.381, p.1048

Doshi, Peter

2023

Link zum Volltext

Verfügbarkeit prüfen

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies

BMJ (Online), 2017-02, Vol.356, p.j337

2017

Link zum Volltext

Verfügbarkeit prüfen

Data too important to share: do those who control the data control the message?

BMJ (Online), 2016-03, Vol.352, p.i1027

Doshi, Peter

2016

Link zum Volltext

Verfügbarkeit prüfen

No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility

BMJ (Online), 2015-09, Vol.351, p.h4629

Doshi, Peter

2015

Link zum Volltext

Verfügbarkeit prüfen

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data

Health technology assessment (Winchester, England), 2016-05, Vol.20 (42), p.1-242

2016

Link zum Volltext

Verfügbarkeit prüfen

On the ethical requirement to inform patients about potential treatment benefits

BMJ (Online), 2023-06, Vol.381, p.1233

2023

Link zum Volltext

Verfügbarkeit prüfen

"Independent" reanalysis of landmark starch solutions trial was published by original authors

BMJ (Online), 2017-07, Vol.358, p.j3552

Doshi, Peter

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient consent to publication and data sharing in industry and NIH-funded clinical trials

Trials, 2018-05, Vol.19 (1), p.269-269, Article 269

2018

Link zum Volltext

Verfügbarkeit prüfen

Authors' reply to Chiolero, Bannon, and Dickinson

BMJ (Online), 2022-01, Vol.376, p.o170

2022

Link zum Volltext

Verfügbarkeit prüfen

Is this trial misreported? Truth seeking in the burgeoning age of trial transparency

BMJ (Online), 2016-10, Vol.355, p.i5543

Doshi, Peter

2016

Link zum Volltext

Verfügbarkeit prüfen

Covid-19 vaccines and treatments: we must have raw data, now

BMJ (Online), 2022-01, Vol.376, p.o102

2022

Link zum Volltext

Verfügbarkeit prüfen

Update: New England Journal of Medicine publishes correction to 2012 CHEST trial of hydroxyethyl starch versus colloids

BMJ (Online), 2016-03, Vol.352, p.i1571

Doshi, Peter

2016

Link zum Volltext

Verfügbarkeit prüfen

Convicting Zika

BMJ (Online), 2016-04, Vol.353, p.i1847

Doshi, Peter

2016

Link zum Volltext

Verfügbarkeit prüfen

Trends in Recorded Influenza Mortality: United States, 1900-2004

American journal of public health (1971), 2008-05, Vol.98 (5), p.939-945

Doshi, Peter

2008

Link zum Volltext

Verfügbarkeit prüfen

Speeding new antibiotics to market: a fake fix?

BMJ (Online), 2015-03, Vol.350, p.h1453

Doshi, Peter

2015

Link zum Volltext

Verfügbarkeit prüfen

21st century cures: is US medicines bill a colossal mistake?

BMJ (Online), 2015-07, Vol.351, p.h4013

Doshi, Peter

2015

Link zum Volltext

Verfügbarkeit prüfen

Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing

BMJ (Online), 2016-01, Vol.352, p.h6849

Doshi, Peter

2016

Link zum Volltext

Verfügbarkeit prüfen

The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors

Systematic reviews, 2018-08, Vol.7 (1), p.117-117, Article 117

2018

Link zum Volltext

Verfügbarkeit prüfen

Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents

JAMA internal medicine, 2013-11, Vol.173 (21), p.2009

Doshi, Peter

2013

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccines: time for a rethink

JAMA internal medicine, 2013-06, Vol.173 (11), p.1014

Doshi, Peter

2013

Link zum Volltext

Verfügbarkeit prüfen

Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests

Clinical infectious diseases, 2020-12

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 413

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(301)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(228)
Journals@OVID
(216)
EZB*
(180)
Ingenta
(158)
Publisher website
(99)
ScienceDirect
(90)
IngentaConnect Journals
(74)
BMJ
(72)
JSTOR
(59)
Wiley Online Library Journals Frontfile Complete
(53)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(39)
Wiley Online Library
(30)
SpringerLink (Online service)
(23)
Applied Social Sciences Index & Abstracts (ASSIA)
(20)
Psychology & Behavioral Sciences Collection (EBSCOhost)
(16)
Business Source Ultimate
(15)
Oxford journals
(15)
Oxford Journals 2020 Medicine
(15)
IEEE Electronic Library Online
(14)
Nexis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The elusive definition of pandemic influenza

The imperative to share clinical study reports: recommendations from the Tamiflu experience

Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry

Covid-19 vaccine trial protocols released

Did the FDA break its own rules in approving the antibiotic Recarbrio?

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies

Data too important to share: do those who control the data control the message?

No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data

On the ethical requirement to inform patients about potential treatment benefits

"Independent" reanalysis of landmark starch solutions trial was published by original authors

Patient consent to publication and data sharing in industry and NIH-funded clinical trials

Authors' reply to Chiolero, Bannon, and Dickinson

Is this trial misreported? Truth seeking in the burgeoning age of trial transparency

Covid-19 vaccines and treatments: we must have raw data, now

Update: New England Journal of Medicine publishes correction to 2012 CHEST trial of hydroxyethyl starch versus colloids

Convicting Zika

Trends in Recorded Influenza Mortality: United States, 1900-2004

Speeding new antibiotics to market: a fake fix?

21st century cures: is US medicines bill a colossal mistake?

Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing

The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors

Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents

Influenza vaccines: time for a rethink

Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests

Suchergebnisse filtern